With the continuous update of gene detection technology, epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have become an essential method for precision treatment of NSCLC [4]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.